BigBear.ai heads into its May 5 Q1 report as one of the most heavily shorted small-cap AI names on the market, even as the stock climbs.
Short sellers have dug in deep. At 28.2% of the free float, short interest is substantial — and despite a modest 3.4% week-on-week reduction, bears have barely budged. The ORTEX short score of 70.8 ranks in the 5th percentile universe-wide, placing BBAI among the most shorted stocks across the platform. Availability in the lending pool has tightened sharply: the lending market is close to fully used, with the 52-week peak having previously hit 100% utilised. Borrowing costs jumped nearly 38% over the past week to 2.55% — a notable acceleration, even if the absolute rate remains moderate. The stock itself has rebounded hard: up 4% on Friday, 12% on the week, and 18% over the past month to close at $4.14.
Options positioning cuts against the cautious short setup. The put/call ratio has fallen to 0.33, well below its 20-day average of 0.35 and nearly 1.75 standard deviations below that mean — pointing toward unusually heavy call-side activity into the print. That's the most bullishly-skewed options positioning of the past year, approaching the 52-week low of 0.26. Bulls appear to be reaching for upside, not hedging against downside.
The underlying debate reflects a company at a genuine inflection point. Bulls point to improving balance-sheet conditions, government AI spending tailwinds, and the Ask Sage product targeting roughly $25 million in annual recurring revenue this year — roughly six times the prior-year level. Bears have harder numbers to work with: Q3 2025 revenue came in at $33.1 million against $41.5 million a year earlier, and full-year guidance was revised down sharply from a $160–$180 million range to $125–$140 million. Gross margin eroded to 22.4%, below both estimates and the prior-year figure. The only analyst changes on record are from early March — both Cantor Fitzgerald and HC Wainwright cut targets after that disappointment, leaving the consensus mean target at $5.33, a 29% premium to Friday's close but from a very thin three-analyst pool.
Institutional buyers have been adding. BlackRock added 11.8 million shares through Q1, and Vanguard added 5.1 million — together holding nearly 15% of the company. That passive and semi-passive accumulation contrasts with a cluster of insider selling: CEO Kevin McAleenan, CFO Sean Ricker, and General Counsel Carolyn Blankenship all sold shares in late March and early April, at prices between $3.04 and $3.52. The values were modest in aggregate, but the simultaneous action across C-suite and legal is worth noting ahead of the print.
The May 5 report will test whether BBAI's revenue trajectory has stabilised — and whether any visibility into the Ask Sage ramp is enough to justify an options market that is positioned for the upside while a near-record short base waits for a different outcome.
See the live data behind this article on ORTEX.
Open BBAI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
